Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Wahren

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|November 26, 2009
Precise determination of glucose-d(2)/glucose ratio in human serum and plasma by APCI LC-MS/MSShahid Ullah, John Wahren, Olof Beck
Pediatric Diabetes|December 7, 2010
C-peptide and long-term complications of diabetesPatrizia Luppi, Vincenza Cifarelli, John Wahren
The Review of Diabetic Studies : RDS|December 30, 2009
The relevance of C-Peptide in diabetes and its complications: an introduction to the special issueAnders A F Sima, John Wahren
Diabetes/Metabolism Research and Reviews|March 7, 2013
Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes?Patrizia Luppi, Åsa Kallas, John Wahren
The Review of Diabetic Studies : RDS|December 30, 2009
C-Peptide is Relevant in Type 1 Diabetes and its Complications: Summary and Conclusions to the Special IssueJohn Wahren, Anders A F Sima
American Journal of Physiology. Endocrinology and Metabolism|June 12, 2003
C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanismBo-Lennart Johansson, John Wahren, John Pernow
Diabetes|March 24, 2012
The clinical potential of C-peptide replacement in type 1 diabetesJohn Wahren, Asa Kallas, Anders A F Sima
Biomolecular Concepts|November 6, 2014
The structure, molecular interactions and bioactivities of proinsulin C-peptide correlate with a tripartite moleculeMichael Landreh, Jan Johansson, John Wahren, et al.
Diabetes Care|February 18, 2016
Long-Acting C-Peptide and Neuropathy in Type 1 Diabetes: A 12-Month Clinical TrialJohn Wahren, Howard Foyt, Mark Daniels, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
Direct measurements of the permeability surface area for insulin and glucose in human skeletal muscleSoffia Gudbjörnsdóttir, Mikaela Sjöstrand, Lena Strindberg, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Clinical and Laboratory Investigation|November 26, 2009
Precise determination of glucose-d(2)/glucose ratio in human serum and plasma by APCI LC-MS/MSShahid Ullah, John Wahren, Olof Beck
Pediatric Diabetes|December 7, 2010
C-peptide and long-term complications of diabetesPatrizia Luppi, Vincenza Cifarelli, John Wahren
The Review of Diabetic Studies : RDS|December 30, 2009
The relevance of C-Peptide in diabetes and its complications: an introduction to the special issueAnders A F Sima, John Wahren
Diabetes/Metabolism Research and Reviews|March 7, 2013
Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes?Patrizia Luppi, Åsa Kallas, John Wahren
The Review of Diabetic Studies : RDS|December 30, 2009
C-Peptide is Relevant in Type 1 Diabetes and its Complications: Summary and Conclusions to the Special IssueJohn Wahren, Anders A F Sima
American Journal of Physiology. Endocrinology and Metabolism|June 12, 2003
C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanismBo-Lennart Johansson, John Wahren, John Pernow
Diabetes|March 24, 2012
The clinical potential of C-peptide replacement in type 1 diabetesJohn Wahren, Asa Kallas, Anders A F Sima
Biomolecular Concepts|November 6, 2014
The structure, molecular interactions and bioactivities of proinsulin C-peptide correlate with a tripartite moleculeMichael Landreh, Jan Johansson, John Wahren, et al.
Diabetes Care|February 18, 2016
Long-Acting C-Peptide and Neuropathy in Type 1 Diabetes: A 12-Month Clinical TrialJohn Wahren, Howard Foyt, Mark Daniels, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
Direct measurements of the permeability surface area for insulin and glucose in human skeletal muscleSoffia Gudbjörnsdóttir, Mikaela Sjöstrand, Lena Strindberg, et al.
Pageof 5